Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease
Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease
Active, not recruiting · NCT05297812 · Registry updated 2026-01-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Subcutaneous Emphysema, alpha 1-antitrypsin deficiency, hereditary disease, liver disorder, lung disorder, pulmonary emphysema, respiratory system disorder | Active, not recruiting | Not stated | 2026-01-16 | NCT05297812 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Alpha-1 Foundation | 6 |
| Columbia University | 375 |
| National Heart, Lung, and Blood Institute (NHLBI) | 791 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Boston University | Boston | United States | 11 |
| Columbia University | New York | United States | 154 |
| Medical University of South Carolina | Charleston | United States | 628 |
| National Jewish Health | Denver | United States | 72 |
| University of Alabama at Birmingham | Birmingham | United States | 193 |
| University of California - Los Angeles | Los Angeles | United States | 6 |
| University of Chicago | Chicago | United States | 312 |
| University of North Carolina | Chapel Hill | United States | 38 |
| University of Utah | Salt Lake City | United States | 72 |